The guide aims to educate ISCT members, healthcare professionals, and the public about the risks related to the direct-to-consumer regenerative therapy industry, exposing common deceptive marketing tactics read more...
The International Society for Cell & Gene Therapy (ISCT) has filed an amicus curiae brief to support the U.S. government's appeal in U.S.A. v. California Stem Cell Treatment Center, Inc., a case that ruled read more...
The International Society for Cell and Gene Therapy MSC Committee Publishes its Perspectives on ISO/TS22859:2022 and ISO24651:2022 with Details of their Extensive Input in the Development of these International read more...
International Society for Cell & Gene Therapy Publishes Report Exploring Areas for Potential Misuse and Outlines Plans for Future Guidelines to Keep Patients Safe VANCOUVER, British Columba May read more...
Vancouver, Canada, April 3, 2023 - The International Society for Cell & Gene Therapy (ISCT), the global society of over 3000 members dedicated to the translation of cell and gene therapies (CGT) into read more...
ISCT provided post-pandemic venue for the entire cell and gene therapy sector to generate solutions to the major barriers to providing therapies to patients Vancouver, read more...
ISCT issues response to US federal judge ruling on FDA regulation of cell and gene therapies US federal judge ruling of significant concern, with widespread implications for cell and gene therapy read more...
ISCT addresses manufacturing standardization, a critical issue constraining the CGT development pipeline Key insights published from ISCT 2022 Commercialization Signature Series Vancouver, read more...
ISCT & CMaT to roll out additional training programs following successful global launch of 'Workforce Development in Biomanufacturing' course The collaboration seeks to address the critical read more...
ISCT announces recipients of key 2022 achievement awards in cell and gene therapy Vancouver, Canada, April 07, 2022 - The International Society read more...